Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

BACKGROUND: Accurate prediction of outcome for metastatic renal cell carcinoma (mRCC) patients receiving targeted therapy is essential. Most of the available models have been developed in patients treated with cytokines, while most of them are fairly complex, including at least five factors. We deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Bamias, A, Tzannis, K, Beuselinck, B, Oudard, S, Escudier, B, Diosynopoulos, D, Papazisis, K, Lang, H, Wolter, P, de Guillebon, E, Stravodimos, K, Chrisofos, M, Fountzilas, G, Elaidi, R-T, Dimopoulos, M A, Bamia, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721408/
https://www.ncbi.nlm.nih.gov/pubmed/23807171
http://dx.doi.org/10.1038/bjc.2013.341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721408/
https://www.ncbi.nlm.nih.gov/pubmed/23807171
http://dx.doi.org/10.1038/bjc.2013.341

Ejemplares similares